Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTK787 in Non-Metastatic Androgen Independent Prostate Cancer
NCT00134355Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Jul 2005
- Primary completion
- Nov 2006
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of vatalanib in prostate cancer (PCa), sponsored by University of Michigan Rogel Cancer Center. Started Jul 2005; status: completed.
02
Drugs
vatalanib
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00134355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134355.